A funding boost for NZ’s drug-buying agency Pharmac to pay for cancer drugs is welcome – but it won’t solve underlying issues
- Written by Paula Lorgelly, Professor of Health Economics, University of Auckland, Waipapa Taumata Rau
Hagen Hopkins/Getty ImagesThis week the coalition government made a significant investment in Pharmac, increasing funding by NZ$604 million over the next four years.
In doing so, it delivered on a National Party election promise to fund 13 cancer drugs. Specifically, it will fund seven of those named during the election, while the remaining six...
